ArticleCureus2025
Esophageal Variceal Grading and Platelet Count in Patients With Liver Cirrhosis.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundEsophageal varices represent a critical consequence of liver cirrhosis, with the risk of hemorrhage closely associated with the grade of the varices. Upper gastrointestinal endoscopy (UGIE) is the definitive method for detection; nonetheless, it is invasive and resource-demanding. Recognizing straightforward, non-invasive indicators like platelet count may assist in risk stratification and prioritize endoscopic screening in patients with cirrhosis.
objectiveThis study aimed to ascertain the correlation between esophageal variceal grading and platelet count in individuals with liver cirrhosis and to assess the clinical relevance of thrombocytopenia as a predictor of high-grade varices. MATERIALS AND
methodsThis observational, descriptive study was performed from August 2022 to August 2023. One hundred twenty cirrhotic individuals had a UGIE assessment for esophageal varices. Demographic, clinical, and laboratory data, including platelet counts, were documented. Patients were classified according to platelet count (>150, 100-150, and <100×10⁹/L) and variceal grades (I-III). The correlation between platelet count and variceal grade was evaluated utilizing chi-squared tests, odds ratios (OR), and multivariate logistic regression in IBM SPSS Statistics for Windows, V. 27.0 (IBM Corp., Armonk, NY, USA).
resultsA notable adverse correlation was identified between platelet count and the severity of esophageal varices. Patients exhibiting reduced platelet counts were more predisposed to high-grade (Grade III) varices, with thrombocytopenia <100×10⁹/L serving as an independent predictor of high-grade varices, even after controlling for confounding variables. The Child-Turcotte-Pugh Class C was correlated with high-grade varices, although age and ascites were not significant predictors.
conclusionThrombocytopenia is markedly correlated with advanced stages of esophageal varices and may function as an effective, non-invasive indicator for detecting high-risk cirrhotic patients. Integrating platelet count into clinical decision-making may enhance risk classification and refine endoscopic screening strategies in resource-constrained environments.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.